3 Australian Penny Stocks Backed By Stronger Balance Sheets

Penny stocks sit at the crossroads of today’s biggest market stories, from shifting inflation trends and energy swings to changing expectations for interest rates. The Financially Fit Penny Stocks screener looks for lower priced companies with a focus on financial resilience, which can help you filter out some of the weaker balance sheets often associated with this corner of the market. With global data sending mixed signals on growth, trade and consumer confidence, a rules based way to narrow the field can be valuable. Below, the article highlights 3 stocks from this screener for closer inspection.

DroneShield (ASX:DRO)

Overview: DroneShield is a Sydney based defence technology company that develops and sells hardware and software to detect, track, and neutralise drones for military, security agencies, critical infrastructure, and large public venues around the world.

Operations: DroneShield currently generates all of its A$216.8 million in revenue from Aerospace & Defense solutions, with sales spread across the USA and Australia and Rest of World.

Market Cap: A$2.0b

DroneShield sits at the centre of a growing focus on counter drone defence, moving from one off product wins to repeat procurement across defence and security customers, including NATO and US aligned channels. Analysts expect strong revenue and earnings expansion, but the stock already trades at a premium P/S multiple and management and the board are relatively new, which can add execution risk alongside funding that depends on external borrowing. At the same time, recent high profile deployments, such as its role in airspace safety for the FIFA World Cup 2026 in Kansas City, and the appointment of seasoned defence leaders to the board, suggest the business is building credibility, with the real story sitting in how its order book, margins and contract quality evolve from here.

DroneShield’s shift from one off wins to repeat defence contracts is only half the picture; the analyst forecasts for DroneShield reveals how current expectations stack up against its premium P/S multiple and where execution risk could surprise next.

Sigma Healthcare (ASX:SIG)

Overview: Sigma Healthcare is an Australian pharmacy group that franchises retail chemists such as Chemist Warehouse, Amcal and Discount Drug Stores, wholesales medicines to community pharmacies, and provides logistics and health services to pharmaceutical manufacturers, including online sales.

Operations: Sigma Healthcare generates essentially all of its A$9.5b in revenue from Healthcare related activities, with around A$9.2b from Australia and A$389.8m from international customers.

Market Cap: A$33.7b

Sigma Healthcare catches the eye because it couples large scale pharmacy and logistics earnings with revenue growth that is expected to outpace the wider Australian market, yet it carries a high P/E and a balance sheet funded entirely through external borrowing. Profit margins have cooled from last year and return on equity remains below 20%, while governance flags around board independence and experience mean investors are relying heavily on newer leadership to keep earnings quality high. With the company walking away from a giant Boots UK deal to focus on its home market, the real question is how this mix of growth, valuation, funding risk and disciplined capital allocation fits into your own tolerance for risk and reward.

Sigma Healthcare’s growth story, premium P/E and fully debt funded balance sheet look like they are pulling in different directions, and the 3 key rewards and 1 important warning sign lays out which side of that tension may matter most next

Stanmore Resources (ASX:SMR)

Overview: Stanmore Resources is a Brisbane based miner that explores for, produces, and sells metallurgical coal from a large tenement portfolio in Queensland’s Bowen and Surat basins, supplying steelmakers primarily across Asia and other export markets.

Operations: Stanmore Resources generates about $1.9b in revenue from producing and selling metallurgical and thermal coal, with customers mainly in Asia, followed by Europe and South America.

Market Cap: A$2.4b

Stanmore Resources stands out in the Financially Fit Penny Stocks screener because it combines a low P/S multiple around 0.9x with assets that are tightly linked to steelmaking demand, especially in Asia. However, it remains loss making and carries dividend coverage questions. The investment case hinges on whether cost efficiencies, automation and brownfield projects can turn forecast earnings growth and improving margins into sustainable profitability while revenue is expected to edge down about 0.4% a year. In addition, its interest in Anglo American’s Queensland coal assets could reshape the company, with potential equity raising, higher leverage and greater scale all under consideration.

Stanmore Resources sits at the point where low P/S, brownfield expansion and potential Anglo American asset exposure intersect, and the analysis report for Stanmore Resources lifts the lid on how that mix could reshape the risk reward profile.

The three stocks covered here are just a starting point. The full Financially Fit Penny Stocks screener surfaces 405 more companies that pair lower share prices with balance sheets and cash flows that could support equally compelling narratives. Use Simply Wall St to identify and analyze the specific catalysts, financial traits and business stories that fit your own highest conviction penny stock ideas so you can focus on the opportunities that matter most to you.

Take Control of Your Investment Journey

If Sigma Healthcare or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Fresh stock ideas can move from quiet momentum to full breakout quickly, and once the crowd catches on, the best entry points start dropping, so consider acting early where appropriate.

• Spot cash rich companies quietly building momentum and use the list of solid balance sheet and fundamentals (20 results) to surface financially sound stocks before they move onto everyone else's radar.
• Explore income-focused opportunities by using the 6 dividend fortresses that highlights high yielding companies with the capacity to continue paying dividends.
• Track fast evolving themes by scanning the 19 cryptocurrency and blockchain stocks for stocks positioned around digital assets and blockchain infrastructure while they may still be under the radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com